Skip to content

Evaluating the effectiveness of herbal toothpaste in the reduction of tooth debris and gum diseases in adults

Evaluation of efficacy and acceptability of herbal toothpaste in the reduction of plaque and gingival inflammation in healthy adult population – A Multicentric pilot study. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062753
Enrollment
300
Registered
2024-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dabur red toothpaste: Tooth paste to be used for brushing twice daily for 3 months Control Intervention1: Not applicable: Not applicable

Sponsors

Dabur Research & Development Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with plaque scores above 1 Subjects with gingival scores between 1 and 2 Subjects showing signs of mild marginal gingival inflammation

Exclusion criteria

Exclusion criteria: Subjects with gingival scores more than 2 Subjects with a known history or present condition of hypersensitivity to any toothpaste, The use of antibiotics, antimicrobial, analgesic medications, mouthwash, or desensitizing toothpaste during the previous one month, Any history of periodontal therapy by surgical interventions, History of dentine hypersensitivity treatment History of smoking or smokless tobacco products Subjects who are pregnant, lactating or nursing Subjects with severe calculus or tartar Subjects with uncontrolled medical illness like HIV, hepatitis etc

Design outcomes

Primary

MeasureTime frame
Changes in the Plaque and Gingival scores Changes in the clinical signs of marginal gingival inflammation Timepoint: Plaque and gingival score to be assessed at 1 monthi.e at 1st followup 2 months i.e at2nd followup and 3 months i.e at 3rd followup

Secondary

MeasureTime frame
Understanding of the products acceptability through survey data pointsTimepoint: acceptability and tolerability to be assessed after 1 month

Countries

India

Contacts

Public ContactDr Ashok Dhoble

Indian Dental Association

ashokdhoble@ida.org.in9820094499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026